Ajer Jeffrey Robert

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
73
Insider Sells Sum
$40.56M

Insider Activity of Ajer Jeffrey Robert

According to the SEC Form 4 filings, Ajer Jeffrey Robert, being in a position of

  1. EVP, Chief Commercial Officer at BioMarin Pharmaceutical Inc.,
    оver the last 12 months, has bought 0 shares, and sold 9000 shares for $762,830,
    over all time since 2012-11-12, has bought 0 shares, and sold 426643 shares for $39.54M.

The largest sale of all time was on 2015-05-06 and amounted to 68038 shares of BioMarin Pharmaceutical Inc. for $8.11M.

Biography of Ajer Jeffrey Robert

No biography is available at this moment.

2024-05-02SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
5,000
0.0026%
$82.91$414,550-8.73%
2024-03-05SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
4,000
0.0021%
$87.07$348,280-4.35%
2023-09-18SaleNektar Therapeutics
NKTR
director
4,359
0.0023%
$0.69$3,008+24.09%
2023-08-16SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
5,000
0.0027%
$90.00$450,000-2.9%
2023-01-25SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
49,000
0.0262%
$115.70$5.67M-20.68%
2022-11-02SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
3,000
0.0017%
$86.12$258,360+9.68%
2022-08-11SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
3,000
0.0016%
$95.62$286,860-2.31%
2022-04-29SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
1,308
0.0007%
$78.94$103,254+11.62%
2022-04-13SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
1,180
0.0006%
$82.47$97,315+6.85%
2022-03-29SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
1,381
0.0008%
$79.56$109,872+11.25%
2022-03-22SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
2,073
0.0011%
$81.00$167,913+7.38%
2021-10-26SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
2,739
0.0015%
$73.60$201,590+15.66%
2021-09-22SaleNektar Therapeutics
NKTR
director
3,665
0.002%
$17.78$65,164-67.74%
2021-04-08SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
1,537
0.0008%
$78.81$121,131+1.83%
2021-03-30SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
1,652
0.0009%
$74.79$123,553+6.14%
2021-03-24SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
1,181
0.0007%
$76.30$90,110+6.38%
2021-03-18SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
1,308
0.0007%
$77.99$102,011+2.47%
2020-10-14SaleBioMarin Pharmaceutical Inc.
BMRN
EVP, Chief Commercial Officer
2,121
0.0012%
$79.91$169,489-0.46%
2020-09-28SaleNektar Therapeutics
NKTR
director
3,250
0.0019%
$17.25$56,063+4.31%
2020-09-21SaleNektar Therapeutics
NKTR
director
2,250
0.0013%
$19.74$44,415-9.58%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.